Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 22 May 2025 for Macrogenics INC. Read the official filing
Filing timeline
BuySaleEdward Hurwitz
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -35.4%Entry US$5.08 · Close at T+365 US$3.28
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Edward Hurwitz: trading record in brief
This profile gathers the share dealings of Edward Hurwitz across 2 companies, led by Macrogenics Inc and Applied Genetic Technologies Corp. In total, 4 filings cover trades dated from 30 November 2022 to 20 May 2025.
On the market, this insider has only ever bought: 1 purchase, €67k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 2 option exercises.
On 22 May 2025 came the latest disclosure, an option exercise in Macrogenics Inc. The most recent open-market purchase was published on 1 September 2023, 1,143 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Edward Hurwitz
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
6,500 sharesCommon StockSEC:0001125345-25-000078:0
4,500 shares0Common StockSEC:0001125345-24-000101:0
15,000 shares@ US$4.91100.0% of flowCommon StockSEC:0001125345-23-000111:0
Canonical exit: 28 Nov 2023 (T+90)
25,672 sharesCommon StockSEC:0001062993-22-023026:0
4 of 4 declarations
